PEPTIDES AND PEPTIDOMIMETICS FOR COMBINED USE AND TREATMENT IN A SUBPOPULATION OF PATIENTS WITH CANCER DISEASES Russian patent published in 2020 - IPC A61K38/03 A61P35/00 

Abstract RU 2732440 C2

FIELD: biotechnology.

SUBSTANCE: disclosed is a method of treating cell proliferation disorders in a mammal, comprising administering a peptide compound containing (d-Bpa)(d-Ser)(d-Trp)(d-Ser)(d-Phe-2,3,4,5,6-F)(d-Cha), or a pharmaceutically acceptable salt thereof, wherein the peptide compound additionally contains an attached or conjugated cell-permeable molecule, wherein the leukocyte content in the mammal is less than approximately 10000 leukocytes per microliter (WBC/mcl) of blood.

EFFECT: present invention can be used in treating tumors.

46 cl, 13 tbl, 6 ex, 20 dwg

Similar patents RU2732440C2

Title Year Author Number
PEPTIDES AND PEPTIDOMIMETICS IN COMBINATION WITH CONTROL POINT INHIBITING AGENTS FOR TREATING CANCER 2016
  • Kawabe, Takumi
RU2739201C2
SELF-ASSEMBLED PEPTIDES IN PREVENTION AND TREATMENT OF CAVITIES ACCOMPANIED BY FORMATION OF CAVITIES 2020
  • Lysek, Dominikus Amadeus
  • Hug, Michael
  • Novy, Brian, B.
RU2828353C2
PEPTIDE ANALOG OF ACYLATED OXYNTOMODULIN 2018
  • Che, Iu-Na
  • Li, Kajung-Seok
  • Che, Yu-Na
  • Baek, Gaje-Rim
  • Kim, Tae-Khajong
  • Yung, Ill-Khun
  • Ryu, Che-Lim
  • Im, Veon-Bin
RU2752787C1
USE OF THE ANTI-O-ACETYLATED GANGLIOSIDE GD2 ANTIBODY FOR IMPROVING THE THERAPEUTIC POTENTIAL OF DRUGS 2017
  • Birkl, Stefan
  • Flerans, Zhyulen
  • Farazh, Sebastyan
  • Le Dussal, Zhan-Mark
  • Koshonno, Deni
  • Term, Mikael
  • Assulin, Brizhitt
RU2771173C2
STRUCTURES HAVING SIRP-ALPHA DOMAIN OR ITS VERSION 2016
  • Ponz Khaume
  • Deming Laura
  • Gudman Kori
  • Sim Bang Dzhanet
  • Kauder Stiven Elliot
  • Van Khun
  • Ko Trejsi Chia-Chien
RU2740672C2
IMMUNOCYTOKINES BASED ON IL-15 AND IL-15Rα OF THE SUSHI DOMAIN 2012
  • Morisso Sebastyan Danel
  • Teppa Zheraldin
  • Zhak Yannik Loran Zhozef
  • Rober Bruno Zhilber Mark
  • De Martinoff Gi Lyuk Mishel
  • Beshar David
RU2763298C2
IMPROVED PEPTIDE DRUGS FOR TREATMENT OF NASH AND OTHER DISORDERS 2019
  • Nestor, John J.
RU2790209C2
THERAPEUTIC USE OF LONG-ACTING TRIPLE AGONIST CONJUGATE HAVING ACTIVITIES ON ALL GLUCAGON/GLP-1/GIP RECEPTORS FOR TREATING LUNG DISEASE 2020
  • Lee Seon Myeong
  • Lee Jong Suk
  • Kim Jung Kuk
  • Lee Sang Hyun
  • Oh Euh Lim
  • Jo Hyo Sang
  • Park Eun Jin
  • Lim Chong Yoon
RU2829342C1
GIP AGONIST COMPOUNDS AND METHODS 2015
  • Shelton Pernilla Tofteng
  • Norregaard Pia
  • Deryabina Mariya Aleksandrovna
  • Larsen Byarn Dyu
  • Fog Dzhejkob Ulrik
RU2716985C2
PEPTIDES AND THEIR USE IN TREATMENT OF DISEASES, DISORDERS OR CONDITIONS ASSOCIATED WITH MUTANT p53 2017
  • Rotter, Varda
  • Oren, Moshe
  • Tal, Perry
  • Eizenberger, Shay
  • Ben-Shimon, Avi
RU2762089C2

RU 2 732 440 C2

Authors

Kavabe Takumi

Mine Naoki

Saito Naoya

Sakakibara Kejiti

Sato Takudzi

Dates

2020-09-16Published

2014-06-24Filed